PNEUMONECTOMY FOR BRONCHOGENIC-CARCINOMA IN THE ELDERLY

被引:36
作者
AU, J
ELOAKLEY, R
CAMERON, EWJ
机构
[1] Department of Thoracic Surgery, City Hospital, Edinburgh, Greenbank Drive
[2] Regional Cardiothoracic Centre, Department of Cardiothoracic Surgery, Wythenshawe Hospital, Manchester, M23 9LT, Southmoor Road
关键词
BRONCHOGENIC CARCINOMA; ELDERLY PATIENTS; PNEUMONECTOMY;
D O I
10.1016/1010-7940(94)90154-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We have reviewed 70 consecutive elderly patients (70 years or older) who underwent pneumonectomy for bronchogenic carcinoma, in order to evaluate morbidity, mortality, and long-term survival. The majority of the patients had stage II (n = 32) or III (n = 25) disease. Fifteen deaths occurred in the peri-operative period (21%). Pre-operative factors associated with peri-operative death included a history of ischaemic heart disease (P = 0.001) and right-sided tumour (peri-operative mortality for right pneumonectomy = 37%, left pneumonectomy = 6%, P = 0.001). Poor lung function (as assessed by pre-operative spirometry), peripheral vascular disease, cerebrovascular disease, diabetes mellitus, and hypertension were not significant risk factors for peri-operative death. Post-operatively, the requirement for ventilation, or the development of post-operative myocardial infarction, adult respiratory distress syndrome and respiratory failure were significantly associated with peri-operative death. Over 60% of the patients developed one or more complications. The absolute survival rates for operative survivors were 51% and 27% at 1 and 5 years, respectively (stage I, 60% and 40%; stage II, 63% and 33%; stage III 33% and 14%). The absolute overall survival rates were 40% and 21% at 1 and 5 years, respectively. We conclude that pneumonectomy is justified in elderly patients but right-sided lesions and ischaemic heart disease should be considered as relative contra-indications.
引用
收藏
页码:247 / 250
页数:4
相关论文
共 26 条
[1]  
Bates M., Results of surgery for bronchial carcinoma in patients aged seventy and over, Thorax, 25, pp. 77-78, (1970)
[2]  
Berggren H., Ekroth R., Malmberg R., Naucler J., William-Olsson G., Hospital mortality and long-term survival in relation to pre-operative function in elderly patients with bronchogenic carcinoma, Ann Thorac Surg, 38, pp. 633-636, (1984)
[3]  
Borrelly J., Grosdidier G., Sibille P., L’exérèse du néoplasme bronchique chez les sujets de 70 ans et plus. A propos d’une série de 193 exérèses, Ann Chir, 42, pp. 130-133, (1992)
[4]  
Breyer R.H., Zippe C., Pharr W.F., Jensik R.J., Kittle C.F., Faber LP Thoracotomy in patients over seventy years, J Thorac Cardiovasc Surg, 81, pp. 187-193
[5]  
Bria W.F., Kanarek D.J., Kazemi H., Prediction of postoperative pulmonary function following thoracic operations: Value of ventilation-perfusion scanning, J Thorac Cardiovasc Surg, 86, pp. 186-192, (1983)
[6]  
Ferguson M.K., Little L., Rizoo R., Popovich K.J., Glonek G.F., Leff A., Manjoney D., Little A., Diffusing capacity predicts morbidity and mortality after pulmonary resection, J Thorac Cardiothorac Surg, 96, pp. 894-900, (1988)
[7]  
Ginsberg R.J., Hill L.D., Eagan R.T., Thomas P., Mountain C.F., Deslauriers J., Fry W., Butz R.O., Goldberg M., Waters P.F., Jones D.P., Pairolero P., Rubinstein L., Pearson F.G., Modern thirty-day operative mortality for surgical resection in lung cancer, J Thorac Cardiovasc Surg, 86, pp. 654-685, (1983)
[8]  
Hepper N., Bernatz P.E., Thoracic surgery in the aged. Diseases of the chest, Chest, 37, pp. 298-303, (1960)
[9]  
Ishida T., Yokoyama H., Kaneko S., Sugio K., Sugimachi K., Long-term results of operation for non-small cell lung cancer in the elderly, Ann Thorac Surg, 50, pp. 919-922
[10]  
Kirsh M.M., Rotman H., Argenta L., Bove E., Cimmino V., Tashi-An J., Ferguson P., Sloan H., Carcinoma of the lung: Results of treatment over ten years, Ann Thorac Surg, 21, pp. 371-377, (1976)